Recent Quotes (30 days)

You have no recent quotes
chg | %

AEterna Zentaris Inc.  

(Public, TSE:AEZ)   Watch this stock  
Find more results for AEZ
-0.01 (-0.79%)
Jul 25 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.26 - 1.26
52 week 1.04 - 1.81
Open 1.26
Vol / Avg. 1,299.00/40,039.00
Mkt cap 71.21M
P/E 8.86
Div/yield     -
EPS 0.14
Shares 56.51M
Beta 1.08
Inst. own     -
Jun 18, 2014
AEterna Zentaris Inc at Bloom Burton & Co Healthcare Investor Conference
May 9, 2014
Q1 2014 AEterna Zentaris Inc Earnings Conference Call
May 8, 2014
Q1 2014 AEterna Zentaris Inc Earnings Release

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -441.13%
Operating margin - -444.96%
EBITD margin - -411.89%
Return on average assets -28.57% -42.94%
Return on average equity -103.09% -525.41%
Employees 76 -
CDP Score - -


1405 du Parc-Technologique Blvd.
+1-418-6528525 (Phone)
+1-418-9489191 (Fax)

Website links


Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company�s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The development priorities in oncology are the completion of Phase 3 trials with perifosine in colorectal cancer (CRC) and in multiple myeloma (MM), as well as the further advancement of AEZS-108, for which it has completed a Phase 2 trial in advanced endometrial and advanced ovarian cancer. Its pipeline also encompasses other earlier-stage programs in oncology. AEZS-112, which is an oral anticancer agent, which includes three mechanisms of action (tubulin, topoisomerase II and angiogenesis inhibition) has completed a Phase 1 trial in advanced solid tumors and lymphoma.

Officers and directors

David A. Dodd Chairman of the Board, President, Chief Executive Officer
Age: 64
Dennis Turpin CA Chief Financial Officer, Senior Vice President
Richard Sachse M.D., Ph.D. Senior Vice President, Chief Scientific Officer, Chief Medical Officer
Jude Dinges Chief Commercial Officer, Senior Vice President
Elliot Shapiro Corporate Secretary
Amelie Metivier Assistant Secretary
Juergen H. L. Ernst Lead Director
Age: 75
M. Marcel Aubut QC Independent Director
Jose P. Dorais Independent Director
Carolyn Egbert Independent Director